Testing effectiveness (Phase 2)Ended earlyNCT01866553What this trial is testingNilotinib Plus Pegylated Interferon-α2b in CMLWho this might be right forChronic Myeloid Leukemia Amsterdam UMC, location VUmc 20
Testing effectiveness (Phase 2)Study completedNCT00954941What this trial is testingOndansetron Versus Aprepitant Plus Ondansetron for EmesisWho this might be right forHematologic DiseasesAcute Myelogenous LeukemiaMyelodysplastic Syndrome+1 more M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00045305What this trial is testingReduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Eastern Cooperative Oncology Group 17
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT00152139What this trial is testingStem Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forAcute Lymphoblastic LeukemiasAcute Myelocytic LeukemiaChronic Myeloid Leukemia+4 more St. Jude Children's Research Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00028730What this trial is testingTotal-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Early research (Phase 1)Ended earlyNCT00664677What this trial is testingPhase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaWho this might be right forLeukemiasAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)+5 more Erimos Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00081133What this trial is testingArsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04274231What this trial is testingCancer-associated Gene Mutations in CML Treatment With TKIs by NGSWho this might be right forDifferent Gene Between Different TKIs Effection Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Ended earlyNCT01640301What this trial is testingLaboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell TransplantWho this might be right forRecurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more Fred Hutchinson Cancer Center 47
Not applicableUnknownNCT00445822What this trial is testingRegistration of Children With CML and Treatment With ImatinibWho this might be right forMyeloid Leukemia, Chronic Technische Universität Dresden 150
Early research (Phase 1)Study completedNCT00006098What this trial is testingPS-341 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00968864What this trial is testingT-cell Depleted Alternative Donor TransplantationWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+6 more Wake Forest University Health Sciences 53
Not applicableStudy completedNCT01394666What this trial is testingNon-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML)Who this might be right forChronic Myeloid Leukemia Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)Study completedNCT00852566What this trial is testingRandomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Norwegian University of Science and Technology 46
Testing effectiveness (Phase 2)Looking for participantsNCT06368414What this trial is testingTreatment-free Remission in Chronic Phase Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia, Chronic Phase Korean Society of Hematology 69
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Early research (Phase 1)Looking for participantsNCT05367700What this trial is testingHS-10382 in Patients With Chronic Myeloid Leukemia.Who this might be right forCML, Chronic PhaseCML, Accelerated Phase Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center